semaglutide/nad Frontiers Addressing the Weight Loss Injectable

brands that ignore it will see their business impacted in small ways and large, and in ways that feel beyond their control.

$30B/yr - Novo's GLP-1 revenue for weight-loss & diabetes now beginning to become exposed to generic options

Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models.I've been reporting on this space in my #Trends report since March 2024two years ago (Navigating Obesity Care in the Digital Age)

Get personalized treatment plans and expert advice for managing your health with Meto's trusted providers.

Particularly India, although a lower adult obesity prevalence, has a large absolute number of patients and prices have already fallen by up to 90% (see pricing section below) in what looks to be a highly competitive market

Looking for laser liposuction or excess skin removal in Gulfport